Massachusetts Financial Services Co. MA Increases Stock Holdings in Axon Enterprise, Inc $AXON

Key Points

• Massachusetts Financial Services increased its stake in Axon by 23% in Q4 to 838,289 shares (about 1.06% of the company) worth $476.1M, and institutional investors now own roughly 79.08% of the stock as several large funds (Vanguard, Jennison, Northern Trust) also added positions.
• Axon is benefiting from product momentum (TASER 10, body cameras, counter‑drone) and a push into AI tools that could lift subscription/software revenue, and it reported 38.5% revenue growth with an EPS beat; however, the stock trades at a rich valuation (PE ≈ 227.6), has recently pulled back and sits below key moving averages, raising downside risk.
• Analysts are generally positive (16 Buys, 3 Holds) with a consensus target of about $755.88, while insiders have sold roughly 13,855 shares (~$7.1M) over the last quarter and now own 4.4% of the company.

Massachusetts Financial Services Co. MA lifted its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 23.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 838,289 shares of the biotechnology company's stock after purchasing an additional 156,647 shares during the quarter. Massachusetts Financial Services Co. MA owned about 1.06% of Axon Enterprise worth $476,089,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in shares of Axon Enterprise by 4.2% in the third quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company's stock valued at $6,684,217,000 after purchasing an additional 376,904 shares during the period. Jennison Associates LLC grew its holdings in shares of Axon Enterprise by 53.8% in the third quarter. Jennison Associates LLC now owns 943,944 shares of the biotechnology company's stock valued at $677,412,000 after purchasing an additional 330,213 shares during the period. Northern Trust Corp grew its holdings in shares of Axon Enterprise by 1.6% in the third quarter. Northern Trust Corp now owns 743,926 shares of the biotechnology company's stock valued at $533,871,000 after purchasing an additional 11,726 shares during the period. Legal & General Group Plc grew its holdings in shares of Axon Enterprise by 3.1% in the third quarter. Legal & General Group Plc now owns 421,114 shares of the biotechnology company's stock valued at $302,208,000 after purchasing an additional 12,736 shares during the period. Finally, Assenagon Asset Management S.A. grew its holdings in shares of Axon Enterprise by 57.3% in the fourth quarter. Assenagon Asset Management S.A. now owns 207,429 shares of the biotechnology company's stock valued at $117,805,000 after purchasing an additional 75,567 shares during the period. Hedge funds and other institutional investors own 79.08% of the company's stock.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Connected Devices momentum — Reports note strong demand for TASER 10 units, body cameras and counter‑drone tech, driving growth in Axon’s Connected Devices segment and suggesting upside to hardware and accessory revenue. Axon's Connected Devices Strength Holds Firm
• Positive Sentiment: New AI product push — Axon unveiled three AI tools aimed at tackling public‑safety data overload, which could boost subscription/software revenue and make its hardware more sticky to agency customers. Product innovation is being cited as a catalyst for longer‑term recurring revenue growth. Axon tackles public safety’s data overload with three new AI tools
• Positive Sentiment: Conference/analyst optimism lifted shares earlier — Coverage noted a rebound after Axon’s annual conference and AI product messaging, indicating some analysts view recent innovation as supportive of the growth story. Axon Enterprise stock rises 4% on analyst optimism
• Neutral Sentiment: Analyst views are mixed — Coverage highlights conflicting analyst sentiments on Axon (some bullish on devices/software, others cautious), contributing to short‑term uncertainty in the stock. Analysts Have Conflicting Sentiments on These Industrial Goods Companies
• Negative Sentiment: Sharp recent sell‑off and volatility — Reports show a large one‑day decline in early April, reflecting profit‑taking and heightened sensitivity to guidance/valuation; that pullback is pressuring the stock despite the product and demand narrative. Axon Enterprise (AXON) Stock Drops Despite Market Gains
• Negative Sentiment: High valuation and technical weakness — Axon still trades at a rich P/E and sits well below its 50‑ and 200‑day moving averages, which increases downside risk if execution or guidance disappoints. Axon Enterprise (AXON) Stock Drops Despite Market Gains

Axon Enterprise Trading Down 1.5%

Shares of AXON stock opened at $345.94 on Friday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 2.29. The firm has a market cap of $27.81 billion, a PE ratio of 227.59, a price-to-earnings-growth ratio of 7.38 and a beta of 1.61. The company has a 50-day moving average of $464.41 and a two-hundred day moving average of $565.36. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.55. The company had revenue of $796.72 million during the quarter, compared to analyst estimates of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. Axon Enterprise's revenue was up 38.5% compared to the same quarter last year. During the same quarter last year, the firm posted $2.08 earnings per share. On average, analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Insider Activity at Axon Enterprise

In other news, Director Erika Nardini sold 198 shares of the firm's stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $506.58, for a total value of $100,302.84. Following the completion of the transaction, the director owned 1,946 shares of the company's stock, valued at approximately $985,804.68. This trade represents a 9.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Isaiah Fields sold 2,000 shares of the firm's stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $535.01, for a total transaction of $1,070,020.00. Following the completion of the transaction, the insider directly owned 55,588 shares of the company's stock, valued at approximately $29,740,135.88. The trade was a 3.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 13,855 shares of company stock valued at $7,109,828 over the last quarter. 4.40% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of brokerages recently issued reports on AXON. Morgan Stanley reissued an "overweight" rating on shares of Axon Enterprise in a report on Wednesday. Needham & Company LLC dropped their price objective on shares of Axon Enterprise from $870.00 to $600.00 and set a "buy" rating for the company in a report on Friday, February 20th. Citigroup reissued a "buy" rating on shares of Axon Enterprise in a report on Wednesday, February 25th. Craig Hallum reaffirmed a "buy" rating and set a $820.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 25th. Finally, Northcoast Research raised shares of Axon Enterprise from a "neutral" rating to a "buy" rating and set a $742.00 target price for the company in a research note on Tuesday, January 6th. Sixteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Axon Enterprise presently has an average rating of "Moderate Buy" and a consensus target price of $755.88.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.